These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 18515801)
21. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Mosig RA; Dowling O; DiFeo A; Ramirez MC; Parker IC; Abe E; Diouri J; Aqeel AA; Wylie JD; Oblander SA; Madri J; Bianco P; Apte SS; Zaidi M; Doty SB; Majeska RJ; Schaffler MB; Martignetti JA Hum Mol Genet; 2007 May; 16(9):1113-23. PubMed ID: 17400654 [TBL] [Abstract][Full Text] [Related]
22. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180 [TBL] [Abstract][Full Text] [Related]
23. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. Dourdin N; Bhatt AK; Dutt P; Greer PA; Arthur JS; Elce JS; Huttenlocher A J Biol Chem; 2001 Dec; 276(51):48382-8. PubMed ID: 11602605 [TBL] [Abstract][Full Text] [Related]
24. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492 [TBL] [Abstract][Full Text] [Related]
25. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339 [TBL] [Abstract][Full Text] [Related]
27. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone. Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727 [TBL] [Abstract][Full Text] [Related]
28. Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnover. Droscha CJ; Diegel CR; Ethen NJ; Burgers TA; McDonald MJ; Maupin KA; Naidu AS; Wang P; Teh BT; Williams BO Bone; 2017 May; 98():68-78. PubMed ID: 28384511 [TBL] [Abstract][Full Text] [Related]
29. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. Chung DJ; Castro CH; Watkins M; Stains JP; Chung MY; Szejnfeld VL; Willecke K; Theis M; Civitelli R J Cell Sci; 2006 Oct; 119(Pt 20):4187-98. PubMed ID: 16984976 [TBL] [Abstract][Full Text] [Related]
30. Deficiency of Capn4 gene inhibits nuclear factor-κB (NF-κB) protein signaling/inflammation and reduces remodeling after myocardial infarction. Ma J; Wei M; Wang Q; Li J; Wang H; Liu W; Lacefield JC; Greer PA; Karmazyn M; Fan GC; Peng T J Biol Chem; 2012 Aug; 287(33):27480-9. PubMed ID: 22753411 [TBL] [Abstract][Full Text] [Related]
31. Constitutive β-catenin activation in osteoblasts impairs terminal osteoblast differentiation and bone quality. Bao Q; Chen S; Qin H; Feng J; Liu H; Liu D; Li A; Shen Y; Zhong X; Li J; Zong Z Exp Cell Res; 2017 Jan; 350(1):123-131. PubMed ID: 27865936 [TBL] [Abstract][Full Text] [Related]
32. Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. de Frutos CA; Dacquin R; Vega S; Jurdic P; Machuca-Gayet I; Nieto MA EMBO J; 2009 Mar; 28(6):686-96. PubMed ID: 19197242 [TBL] [Abstract][Full Text] [Related]
33. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. Safadi FF; Xu J; Smock SL; Kanaan RA; Selim AH; Odgren PR; Marks SC; Owen TA; Popoff SN J Cell Physiol; 2003 Jul; 196(1):51-62. PubMed ID: 12767040 [TBL] [Abstract][Full Text] [Related]
34. Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis. Adhami MD; Rashid H; Chen H; Clarke JC; Yang Y; Javed A J Bone Miner Res; 2015 Jan; 30(1):71-82. PubMed ID: 25079226 [TBL] [Abstract][Full Text] [Related]
35. Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. Wu JY; Aarnisalo P; Bastepe M; Sinha P; Fulzele K; Selig MK; Chen M; Poulton IJ; Purton LE; Sims NA; Weinstein LS; Kronenberg HM J Clin Invest; 2011 Sep; 121(9):3492-504. PubMed ID: 21804192 [TBL] [Abstract][Full Text] [Related]
36. T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone. Pacifici R Ann N Y Acad Sci; 2016 Jan; 1364(1):11-24. PubMed ID: 26662934 [TBL] [Abstract][Full Text] [Related]
37. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659 [TBL] [Abstract][Full Text] [Related]
39. N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms. Di Benedetto A; Watkins M; Grimston S; Salazar V; Donsante C; Mbalaviele G; Radice GL; Civitelli R J Cell Sci; 2010 Aug; 123(Pt 15):2640-8. PubMed ID: 20605916 [TBL] [Abstract][Full Text] [Related]
40. Inactivation of Ihh in Sp7-Expressing Cells Inhibits Osteoblast Proliferation, Differentiation, and Bone Formation, Resulting in a Dwarfism Phenotype with Severe Skeletal Dysplasia in Mice. Wang Y; Dong Z; Yang R; Zong S; Wei X; Wang C; Guo L; Sun J; Li H; Li P Calcif Tissue Int; 2022 Nov; 111(5):519-534. PubMed ID: 35731246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]